Fmr LLC Verve Therapeutics, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 1,415,120 shares of VERV stock, worth $9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,415,120

Previous 3,377,474 58.1%

Holding current value

$9 Million

Previous $44.9 Million 84.6%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$4.76 - $12.79 $9.34 Million - $25.1 Million	-1,962,354 Reduced 58.1%	1,415,120 $6.91 Million
Q1 2024 May 13, 2024	SELL	$10.81 - $17.96 $725,307 - $1.21 Million	-67,096 Reduced 1.95%	3,377,474 $44.9 Million
Q4 2023 Feb 13, 2024	SELL	$8.84 - $18.7 $27.7 Million - $58.6 Million	-3,132,992 Reduced 47.63%	3,444,570 $48 Million
Q3 2023 Nov 13, 2023	BUY	$11.42 - $20.82 $6.07 Million - $11.1 Million	531,182 Added 8.79%	6,577,562 $87.2 Million
Q2 2023 Aug 11, 2023	SELL	$13.34 - $19.9 $10.4 Million - $15.5 Million	-780,437 Reduced 11.43%	6,046,380 $113 Million
Q1 2023 May 11, 2023	SELL	$14.3 - $24.01 $1.12 Million - $1.89 Million	-78,606 Reduced 1.14%	6,826,817 $98.4 Million
Q4 2022 Feb 13, 2023	SELL	$17.85 - $40.7 $10.3 Million - $23.5 Million	-576,927 Reduced 7.71%	6,905,423 $134 Million
Q3 2022 Nov 10, 2022	BUY	$15.63 - $41.49 $33.9 Million - $89.9 Million	2,166,571 Added 40.76%	7,482,350 $257 Million
Q2 2022 Aug 12, 2022	BUY	$11.14 - $23.17 $2.23 Million - $4.63 Million	199,869 Added 3.91%	5,315,779 $81.2 Million
Q1 2022 May 13, 2022	BUY	$20.92 - $39.36 $2.39 Million - $4.5 Million	114,427 Added 2.29%	5,115,910 $117 Million
Q4 2021 Feb 14, 2022	BUY	$31.94 - $54.82 $48.5 Million - $83.3 Million	1,519,602 Added 43.64%	5,001,483 $184 Million
Q3 2021 Nov 15, 2021	BUY	$46.0 - $73.99 $1.48 Million - $2.37 Million	32,087 Added 0.93%	3,481,881 $164 Million
Q2 2021 Aug 13, 2021	BUY	$31.92 - $60.25 $110 Million - $208 Million	3,449,794 New	3,449,794 $208 Million

Others Institutions Holding VERV

# of Institutions

175

Shares Held

69.5M

Call Options Held

115K

Put Options Held

144K

View Full List

About Verve Therapeutics, Inc.

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $381M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

More about VERV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account